Itaan Pharma Private Limited, a active private limited company, was established on 04 May 2020 in Guntur, Andhra Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230AP2020PTC114523. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹95.00 Cr and a paid-up capital of ₹89.28 Cr.
It upholds a compliant status. Employing 80 professional, Its leadership includes Prasanna Sagar (Director), Kankanala Chenchu Babu (Director), Chandu Kankanala (Director). Past directors included Prasanna Sagar, Kankanala Chenchu Babu, Chirukuri Kumar Ramana. It holds ₹46.54 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at D.No. 4-5-29/32C, Gmc No.28, Vidya Nagar, 1St Line,, Guntur, Andhra Pradesh, 522007.
U24230AP2020PTC114523
114523
04 May 2020
₹95.00 Cr
₹89.28 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Itaan Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prasanna Sagar | Director | 20 Apr 2022 | Current |
| Kankanala Chenchu Babu | Director | 04 Sep 2024 | Current |
| Chandu Kankanala | Director | 04 May 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2024 | Past |
| Pramod Abcsdd | Managing Director | 02 Sep 2024 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Itaan Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Itaan Pharma had a promoter holding of 52.50% and a public holding of 47.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹465,350,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Aug 2023 | Others | ₹1.54 Cr | Open |
| 15 Mar 2023 | Others | ₹45.00 Cr | Open |
Explore comprehensive loan charge details -
Itaan Pharma has a workforce of 80 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Itaan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Itaan Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Itaan Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Itaan Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was recorded as a recent event.
Progress on Prasanna Sagar was appointed as a Ceo was appointed as a Ceo on 19 Oct 2024 & has been associated with this company since 1 year 2 months . was documented.
The activity Kankanala Chenchu Babu was appointed as a Director was appointed as a Director on 04 Sep 2024 & has been associated with this company since 1 year 3 months . was completed.
Progress on Saad Khan was appointed as a Company Secretary was appointed as a Company Secretary on 26 Feb 2024 & has been associated with this company since 1 year 9 months . was documented.
A charge with Others amounted to Rs. 1.54 Cr with Charge ID 100772541 was registered on 05 Aug 2023. was recorded as a recent event.
The CIN of Itaan Pharma Private Limited is U24230AP2020PTC114523.
Itaan Pharma Private Limited is headquartered at D.No. 4-5-29/32C, Gmc No.28, Vidya Nagar, 1St Line,, Guntur, Andhra Pradesh, 522007.
Itaan Pharma Private Limited was incorporated on 04 May 2020.
The current directors of Itaan Pharma Private Limited are
The primary industry of Itaan Pharma Private Limited is Manufacturing.
Itaan Pharma Private Limited is unlisted.
The authorized capital of Itaan Pharma Private Limited is ₹95.00 Cr, and the paid-up capital is ₹89.28 Cr.
The compliance status of Itaan Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX